Active Ingredient Octreotide Acetate

Active Ingredient Details

What is the usage for Octreotide Acetate?

Octreotide is used to treat severe watery diarrhea and sudden reddening of the face and neck caused by certain types of tumors (such as carcinoid tumors, vasoactive intestinal peptide tumors) that are found usually in the intestines and pancreas. The symptoms occur when these tumors make too much of certain natural substances (hormones). This medication works by blocking the production of these hormones. By decreasing watery diarrhea, octreotide helps to reduce the loss of body fluids and minerals. Octreotide is also used to treat a certain condition (acromegaly) that occurs when the body makes too much of a certain natural substance called growth hormone. Treating acromegaly helps reduce the risk of serious problems such as diabetes and heart disease. Octreotide works by decreasing the amount of growth hormone to normal levels. This drug is not a cure for these conditions. This medication is usually used with other treatment (such as surgery, radiation, other drugs).

How many products in the NDC database contain Octreotide Acetate?

The NDC database has 53 products with the active ingredient Octreotide Acetate. The following table lists all the products that have this active ingredient.

NDC Products with Octreotide Acetate

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0078-0180Proprietary Name: Sandostatin Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousNovartis Pharmaceuticals CorporationACTIVE
0078-0181Proprietary Name: Sandostatin Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousNovartis Pharmaceuticals CorporationACTIVE
0078-0182Proprietary Name: Sandostatin Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousNovartis Pharmaceuticals CorporationACTIVE
0641-6174Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0641-6175Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0641-6176Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0641-6177Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0641-6178Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
23155-685Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; IntravenousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
23155-686Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
23155-687Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
23155-688Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
23155-689Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
25021-463Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
25021-464Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
25021-465Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
25021-466Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
25021-467Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
32861-0005Proprietary Name: Octreotide AcetatePowderChengdu Shengnuo Biopharm Co. Ltd.ACTIVE
35207-0002Proprietary Name: OctreotidePowderBcn Peptides SaACTIVE
50384-6400Proprietary Name: Octreotide AcetatePowderSterling Pharma Solutions LimitedACTIVE
52416-109Proprietary Name: OctreotidePowderBachem Americas, Inc.ACTIVE
52416-118Proprietary Name: OctreotidePowderBachem Americas, Inc.ACTIVE
52416-123Proprietary Name: Octreotide AcetatePowderBachem Americas, Inc.ACTIVE
55463-0035Proprietary Name: Octreotide AcetatePowderBachem AgACTIVE
59149-007Proprietary Name: Octreotide AcetatePowderPolypeptide Laboratories, Pvt. Ltd.ACTIVE
59651-004Proprietary Name: Octreotide AcetatePowderAurobindo Pharma LimitedACTIVE
63323-376Proprietary Name: Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-376Proprietary Name: Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-376Proprietary Name: Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-376Proprietary Name: Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-377Proprietary Name: Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-377Proprietary Name: Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-377Proprietary Name: Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-377Proprietary Name: Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-378Proprietary Name: Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-379Proprietary Name: Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63415-0065Proprietary Name: Octreotide AcetatePowderAssia Chemical Industries Ltd - Teva Tech SiteACTIVE
65015-840Proprietary Name: Octreotide AcetatePowderMylan Laboratories LimitedACTIVE
65129-1049Proprietary Name: Octreotide AcetatePowderScinopharm Taiwan Ltd.ACTIVE
66558-0192Proprietary Name: Octreotide AcetatePowderFresenius Kabi Ipsum SrlACTIVE
67457-239Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousMylan Institutional LlcACTIVE
67457-245Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousMylan Institutional LlcACTIVE
67457-246Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousMylan Institutional LlcACTIVE
68083-515Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousGland Pharma LimitedACTIVE
68083-516Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousGland Pharma LimitedACTIVE
68083-517Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousGland Pharma LimitedACTIVE
68083-560Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousGland Pharma LimitedACTIVE
68462-896Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousGlenmark Pharmaceuticals Inc., UsaACTIVE
68462-897Proprietary Name: Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousGlenmark Pharmaceuticals Inc., UsaACTIVE
73301-004Proprietary Name: OctreotidePowderLsne, Inc.ACTIVE
76177-119Proprietary Name: Octreotide AcetatePowderSinopep-allsino Biopharmaceutical Co., Ltd.ACTIVE
84147-001Proprietary Name: Octreotide AcetatePowderChemical & Biopharmaceutical Laboratories Of Patras S.a.ACTIVE
<